ConductScience.org, home

Comparison · NCT01995487-deaths

BioNIR vs Resolute: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. BioNIR vs Resolute: deaths from any cause. Trial comparisons, record NCT01995487-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01995487-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.005220.002230.0122wilson
Risk in group 20.002080.0005710.00756wilson
Risk difference, group 1 minus group 20.00314-0.00310.0102newcombe hybrid score
Risk ratio, group 1 over group 22.510.48812.9log
Odds ratio, group 1 over group 22.520.48713log
Number needed to harm, for one more death from any cause on BioNIR than on Resolute319from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1BioNIR
Subjects received The BioNIR Ridaforolimus Eluting Coronary Stent System is a single use device/drug combination product comprising:~* Stent - a mounted Cobalt Chromium (CoCr) alloy based stent~* Delivery System - Rapid Exchange (RX) Coronary System~* Polymer matrix coating - Poly n-butyl methacrylate (PBMA) and CarboSil®~* Ridaforolimus drug - CAS Registry Number: 572924-54-0~The drug Ridaforolimus is utilized on the stent system at a dose of 1.1 μg/mm2 (with a drug load of 100 μg per 2.75/3.00 x 17 mm stent).~BioNIR: drug-eluting stent
5958EG000
Group 2Resolute
Subjects received The Endeavor Resolute Zotarolimus-Eluting Stent System consists of four subsystems:~1. Endeavor Resolute Stent- a pre-mounted cobalt alloy based stent~2. Delivery system (Rapid Exchange \[RX\] Coronary System)~3. Polymer system~4. Zotarolimus - drug The Resolute has a nominal drug dose of 1.6µg Zotarolimus per mm2 of the stent surface area.~Resolute: drug-eluting stent
2961EG001

Harm

What it counts
Total, all-cause mortality
Time frame
The Investigator monitored the occurrence of adverse events for each subject during the whole course of the trial - baseline and post procedure, 30 days, 6 months, 1 year, 2 years, 3 years, 4 years and 5 years visits.

Source ClinicalTrials.gov

Trial

Title
Study of BioNIR Drug Eluting Stent System in Coronary Stenosis
NCT number
NCT01995487
Phases
NA
Conditions
Coronary Artery Stenosis
Interventions
BioNIR, Resolute
Lead sponsor
Medinol Ltd.
Results first posted
2021-02-25

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01995487-deaths